Professional Documents
Culture Documents
Health Guide Chapter 22
Health Guide Chapter 22
com)
Guide to the Evaluation of Post-Travel Illness
Review the Itinerary & Associated Disease Risks
Reviewing the travelers' itinerary suggests possible disease riskand eliminates others. Malaria, for
example, may occur in a traveler returned from Africabut only if the traveler had visited an endemic
area.
The Destination Advisor lists the most common diseases endemic in each country. If outbreaks are
occurring, that will also be noted (or found on the Travel Health Service link for that country).
Abdominal pain
Diarrhea
Weight loss
Fatigue
Skin rash
What countries did you visit and for how long in each? What specific geographic areas did you
visit in each country? Did you visit disease-endemic areas? (For example, in Thailand, malaria
occurs only in certain forested border areas, not in the cities.)
What were your arrival and departure dates? When did you return home?
When did you get sick? Date you first noted your symptoms?
Did you receive any vaccinations prior to departure? Have you been previously immunized
against diseases such as hepatitis A or typhoid? Are your routine immunizations up-to-date?
Please list all the vaccines you received during the past 10 years.
Did you travel in rural areas of tropical/semitropical countries or did you stay exclusively in
urban areas and stay in high-end, air-conditioned hotels. Did you stay exclusively in a resort?
Did you take insect-bite prevention measures (e.g., use DEET skin repellents, sleep under a
bednet)?
Did you adhere to safe food and drink guidelines? Did you eat snails, crabs, prawns, raw fish, or
inadequately cooked or raw exotic foods made from beef, pork, bear, walrus, or fish? Did you
use a water filter or purifier? Drink only bottled water or beverages?
Did you get sick during your trip? If you were in a group, did others get sick? Did you self-treat
for diarrhea or other illness? Did you have an illness with fever while abroad.
Were you treated in a clinic, a doctor's office, or in your hotel? Were you hospitalized? Where?
What was your diagnosis, if any? Were any tests done? Were you treated with medications.
Which ones? Did you get any shots? Did the medical personnel use sterile equipment?
Unsafe food and drink - Did you eat undercooked or raw meat or fish (e.g., sushi); cold food and
salads from buffets or salad bars; street vendor food not well-cooked? Did you drink tap water or
untreated water from lakes, streams or ponds? Did you consume unpasteurized dairy products
(e.g., raw milk, cheese)? Did you handle freshly slaughtered animals?
Insect and animals bites - Were you bitten by mosquitoes, flies, or ticks? Were you bitten by a dog
or other animal?
Unprotected sex with a new partner. Did you have same-sex contact?
Recreational drug use (especially by injection), tattooing, body piercing, or surgical procedures.
People with infectious diseases. Did you work in a hospital or refugee camp? Did you have
contact with sick people with respiratory illnesses, such as tuberculosis?
In view of the traveler's symptoms, itinerary, and disease incubation periods, which disease(s) seems
likely?
Laboratory Tests & Imaging Studies
Testing may include microscopy, cultures, biochemical tests, including serology, and polymerase
chain reaction. The laboratory tests commonly available to evaluate post-travel illness include:
Complete blood count to screen for anemia, eosinophilia, elevated or decreased white blood cell
count and/or low platelets.
Thick and thin blood films to screen for malaria (3 times over 24 hours)
Blood cultures
HIV test. Suspect HIV when the WBC count is low, especially low total lymphocyte count
Serology testing (e.g., dengue, brucellosis, leishmaniasis, amebiasis or other parasites, etc.). PCR
testing.
Prevalensi
1. Low risk = U.S, Canada, Australia, Japan, New Zeland
2. Intermediate risk = Afrika selatan, eastern Europe
3. High risk = Asia, Middle East, Africa, Mexico, Central & South America
Resiko
In environments where large numbers of people do not have access to plumbing
or latrines, the amount of stool contamination in the environment will be higher and
more accessible to flies. Inadequate electrical capacity may lead to frequent blackouts
or poorly functioning refrigeration, which can result in unsafe food storage and an
increased risk for disease. Lack of safe water may lead to contaminated foods and
drinks prepared with such water; inadequate water supply may lead to shortcuts in
cleaning hands, surfaces, utensils, and foods such as fruits and vegetables. In addition,
handwashing may not be a social norm and could be an extra expense, thus there may
be no handwashing stations in food preparation areas. In destinations in which effective
food handling courses have been provided, the risk for TD has been demonstrated to
decrease. However, even in developed countries, pathogens such as Shigella sonnei
have caused TD linked to handling and preparation of food in restaurants.
Manifes Klinis
Onset tiba-tiba, gejala mulai dari mild cramps dan urgent loose tools, sampai ke
severe abdominal pain, fever, vomiting, bloody diarrhea (pada norovirus paling
mencolok gejala muntah2)
Inkubasi 6 72 jam
Untreated bacterial: sembuh dalam 3 7 hari, viral : 2 3 hari
Protozoal
Managemen (medscape)
Etiology
Other
Table 3.
Clinical Features of Acute Diarrhea Caused by Select Pathogens
Pathogen
Fever Abdomin
Nausea,
Fecal evidenceBloodyHemeal pain vomiting, or
of inflammation
stool positive
both
stools
Bacterial
Campylobacter
Clostridium difficile
Salmonella
Shiga toxinproducing
Escherichia coli
Shigella
Vibrio
Yersinia
Parasitic
Cryptosporidium
Occurs
Not common
Occurs
Occurs
Common
Common
Common
Not common
Occurs Variable
Occurs Occurs
Occurs Variable
CommonCommon
Common
Variable
Occurs
Common
Variable
Occurs
Occurs Variable
Variable Variable
Occurs Occurs
None to mild
Cyclospora
Not common
Entamoeba histolytica
Giardia
Variable
Not common
Not
Not common
common
Not
Not common
common
Variable Common
Not
Not common
common
Not common
Viral
Norovirus
CommonCommon
Occurs Occurs
CommonCommon
Not
Common
common
CommonCommon
Variable Variable
CommonCommon
Not
Not common
common
Table 4.
Summary of Antibiotic Therapy for Acute Diarrhea
Organism
Therapy Preferred
Alternativ
effectiv
medication
e
eness
medicatio
ns
Bacterial
Campylobacter
Proven in
dysentery
and sepsis,
possibly
effective
in enteritis
Azithromycin
(Zithromax),
500 mg once per
day for 3 to 5
days
Clostridium difficile
Proven
Metronidazole
(Flagyl), 500 mg
three times per
day for 10 days
Enteropathogenic/enteroin
vasive Escherichia coli
Possible
Ciprofloxacin,
500 mg twice
per day for 3
days
Enterotoxigenic E. coli
Proven
Ciprofloxacin,
500 mg twice
per day for 3
days
Salmonella, non-Typhi
species
Doubtful
in
enteritis;
proven in
severe
infection,
Erythromyci
n, 500 mg
four times
per day for 3
to 5 days
Ciprofloxaci
n (Cipro),
500 mg
twice per
day for 5 to7
days
Vancomycin
, 125 mg
four times
per day for
10 days
TMP/SMX
DS, 160/800
mg twice
per day for 3
days
TMP/SMX
DS, 160/800
mg twice
per day for 3
days
Azithromyci
n, 500 mg
per day for 3
days
Options for
severe
disease:
Ciprofloxaci
n, 500 mg
twice per
Comments
Consider
prolonged
treatment if the
patient is
immunocomprom
ised
If an
antimicrobial
agent is causing
the diarrhea, it
should be
discontinued if
possible
Enterotoxigenic
E. coli is the
most common
cause of traveler's
diarrhea
In addition to
patients with
severe disease, it
is appropriate to
treat patients
younger than 12
sepsis, or
dysentery
day for 5 to
7 days
TMP/SMX
DS, 160/800
mg twice
per day for 5
to 7 days
Shiga toxinproducing E.
coli
Controver
sial
No treatment
Shigella
Proven in
dysentery
Ciprofloxacin,
500 mg twice
per day for 3
days, or 2-g
single dose
Vibrio cholerae
Proven
Doxycycline,
300-mg single
dose
months or older
than 50 years,
and patients with
a prosthesis,
valvular heart
disease, severe
atherosclerosis,
malignancy, or
uremia
Azithromyci Patients who are
n, 500 mg
immunocomprom
per day for 5 ised should be
to 7 days
treated for 14
days
No
The role of
treatment
antibiotics is
unclear; they are
generally avoided
because of their
association with
hemolytic uremic
syndrome
Antimotility
agents should be
avoided
Azithromyci Use of
n, 500 mg
TMP/SMX is
twice per
limited because
day for 3
of resistance
days
TMP/SMX
Patients who are
DS, 160/800 immunocomprom
mg twice
ised should be
per day for 5 treated for 7 to 10
days
days
Ceftriaxone
(Rocephin),
2- to 4-g
single dose
Azithromyci Doxycycline and
n, 1-g single tetracycline are
dose
not
Tetracycline recommended in
, 500 mg
children because
four times
Yersinia
Not
needed in
mild
disease or
enteritis,
proven in
severe
disease or
bacteremia
Protozoal
Cryptosporidium
Possible
Therapy may
not be necessary
in
immunocompete
nt patients with
mild disease or
in patients with
AIDS who have
a CD4 cell count
greater than 150
cells per mm3
Cyclospora or Isospora
Proven
TMP/SMX DS,
160/800 mg
twice per day for
severe
disease:
Doxycycline
combined
with an
aminoglycos
ide
TMP/SMX
DS, 160/800
mg twice
per day for 5
days
Ciprofloxaci
n, 500 mg
twice per
day for 7 to
10 days
Option for
severe
disease:
Nitazoxanid
e (Alinia),
500 mg
twice per
day for 3
days (may
offer longer
treatment
for
refractory
cases in
patients with
AIDS)
Highly active
antiretroviral
therapy, which
achieves immune
reconstitution, is
adequate to
eradicate
intestinal disease
in patients with
AIDS
Entamoeba histolytica
Proven
Giardia
Proven
Microsporida
Proven
7 to 10 days
AIDS or
immunosuppress
ion: TMP/SMX
DS, 160/800 mg
twice to four
times per day for
10 to 14 days,
then three times
weekly for
maintenance
Metronidazole,
750 mg three
times per day for
5 to 10 days,
plus
paromomycin,
25 to 35 mg per
kg per day in 3
divided doses
for 5 to 10 days
Metronidazole,
250 to 750 mg
three times per
day for 7 to 10
days
Albendazole
(Albenza), 400
mg twice per
day for 3 weeks
Tinidazole
(Tindamax),
2 g per day
for 3 days,
plus
paromomyci
n, 25 to 35
mg per kg
per day in 3
divided
doses for 5
to 10 days
Tinidazole,
2-g single
dose
Relapses may
occur